These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 9922858

  • 1. [In vitro resistance of Propionibacterium acnes and Staphylococcus epidermidis to antibiotics: should our antibiotic prescription practices for the treatment of acne be changed?].
    Bourgault-Villada I.
    Ann Dermatol Venereol; 1998 Dec; 125(12):879-80. PubMed ID: 9922858
    [No Abstract] [Full Text] [Related]

  • 2. [The resistance of Propionibacterium acnes and Staphylococcus epidermidis to cyclines. The Research and Study Group on Acne].
    Noyon V, Legallou F, Richet H, Dreno B.
    Ann Dermatol Venereol; 1998 Dec; 125(12):885-7. PubMed ID: 9922860
    [Abstract] [Full Text] [Related]

  • 3. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions.
    Nishijima S, Kurokawa I, Katoh N, Watanabe K.
    J Dermatol; 2000 May; 27(5):318-23. PubMed ID: 10875198
    [Abstract] [Full Text] [Related]

  • 4. Antibiotic resistance of microbial strains isolated from Korean acne patients.
    Moon SH, Roh HS, Kim YH, Kim JE, Ko JY, Ro YS.
    J Dermatol; 2012 Oct; 39(10):833-7. PubMed ID: 22779738
    [Abstract] [Full Text] [Related]

  • 5. [General antibiotic therapy in acne].
    Dréno B.
    Rev Prat; 2002 Apr 15; 52(8):841-3. PubMed ID: 12053791
    [Abstract] [Full Text] [Related]

  • 6. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
    Song M, Seo SH, Ko HC, Oh CK, Kwon KS, Chang CL, Kim MB.
    J Dermatol; 2011 Jul 15; 38(7):667-73. PubMed ID: 21352337
    [Abstract] [Full Text] [Related]

  • 7. The antibiotic susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne.
    Nishijima S, Akamatsu H, Akamatsu M, Kurokawa I, Asada Y.
    J Dermatol; 1994 Mar 15; 21(3):166-71. PubMed ID: 8014270
    [Abstract] [Full Text] [Related]

  • 8. A Multifactorial Comparison of Ternary Combinations of Essential Oils in Topical Preparations to Current Antibiotic Prescription Therapies for the Control of Acne Vulgaris-Associated Bacteria.
    Owen L, Grootveld M, Arroo R, Ruiz-Rodado V, Price P, Laird K.
    Phytother Res; 2017 Mar 15; 31(3):410-417. PubMed ID: 28124400
    [Abstract] [Full Text] [Related]

  • 9. Susceptibility of Propionibacterium acnes and Staphylococcus epidermidis to killing by MPO-halide system products. Implication for taurine bromamine as a new candidate for topical therapy in treating acne vulgaris.
    Marcinkiewicz J, Biedroń R, Białecka A, Kasprowicz A, Mak M, Targosz M.
    Arch Immunol Ther Exp (Warsz); 2006 Mar 15; 54(1):61-8. PubMed ID: 16642259
    [Abstract] [Full Text] [Related]

  • 10. Antibiotic resistant Cutibacterium acnes among acne patients in Jordan: a cross sectional study.
    Alkhawaja E, Hammadi S, Abdelmalek M, Mahasneh N, Alkhawaja B, Abdelmalek SM.
    BMC Dermatol; 2020 Nov 17; 20(1):17. PubMed ID: 33203374
    [Abstract] [Full Text] [Related]

  • 11. The development of antimicrobial resistance due to the antibiotic treatment of acne vulgaris: a review.
    Patel M, Bowe WP, Heughebaert C, Shalita AR.
    J Drugs Dermatol; 2010 Jun 17; 9(6):655-64. PubMed ID: 20645527
    [Abstract] [Full Text] [Related]

  • 12. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
    Dreno B, Foulc P, Reynaud A, Moyse D, Habert H, Richet H.
    Eur J Dermatol; 2005 Jun 17; 15(3):152-5. PubMed ID: 15908296
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Erythromycin-resistance of cutaneous bacterial flora in acne.
    Dreno B, Reynaud A, Moyse D, Habert H, Richet H.
    Eur J Dermatol; 2001 Jun 17; 11(6):549-53. PubMed ID: 11701406
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Trends in the treatment of acne vulgaris: are measures being taken to avoid antimicrobial resistance?
    Kinney MA, Yentzer BA, Fleischer AB, Feldman SR.
    J Drugs Dermatol; 2010 May 17; 9(5):519-24. PubMed ID: 20480795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.